Is Shattuck Labs, Inc. (STTK) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.9% / 30% | 19.3% / 30% | 0.0% / 30% | 90.44% / 5% | ✗ NOT HALAL |
| DJIM | 0.9% / 33% | 19.3% / 33% | 0.0% / 33% | 90.44% / 5% | ✗ NOT HALAL |
| MSCI | 3.7% / 33% | 80.2% / 33% | 0.0% / 33% | 90.44% / 5% | ✗ NOT HALAL |
| S&P | 0.9% / 33% | 19.3% / 33% | 0.0% / 33% | 90.44% / 5% | ✗ NOT HALAL |
| FTSE | 3.7% / 33% | 80.2% / 33% | 0.0% / 50% | 90.44% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | -195.1% | |
| Operating Margin | -5142.7% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -60.3% | |
| Return on Assets (ROA) | -35.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$40M |
| Free Cash Flow | -$40M |
| Total Debt | $2M |
| Debt-to-Equity | 2.9 |
| Current Ratio | 11.7 |
| Total Assets | $91M |
Price & Trading
| Last Close | $6.31 |
| 50-Day MA | $4.75 |
| 200-Day MA | $2.60 |
| Avg Volume | 683K |
| Beta | 1.7 |
|
52-Week Range
$0.69
| |
About Shattuck Labs, Inc. (STTK)
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Shattuck Labs, Inc. (STTK) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Shattuck Labs, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Shattuck Labs, Inc.'s debt ratio?
Shattuck Labs, Inc.'s debt ratio is 0.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 3.7%.
What are Shattuck Labs, Inc.'s key financial metrics?
Shattuck Labs, Inc. has a market capitalization of $431M, and revenue of $1M. Return on equity stands at -60.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.